Who owns Kyverna Therapeutics, Inc.?
- Ticker: KYTX
- CUSIP Number: 501976104
Tip: Access positions for across all investors
Analyze quarterly positions in Kyverna Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Kyverna Therapeutics stock
Who bought or sold Kyverna Therapeutics, Inc. this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Vida Ventures Advisors | 4.5M | $27M | 0% | Sep 2025 |
|
| Gilead Sciences | 4.1M | $39M | 0% | Dec 2025 |
|
| Bain Capital Life Sciences Investors | 3.1M | $29M | -8% | Dec 2025 |
|
| Deerfield Management Company | 2.0M | $19M | 100% | Dec 2025 |
|
| Vanguard Group | 1.8M | $17M | 35% | Dec 2025 |
|
| AIGH Capital Management | 1.5M | $14M | 100% | Dec 2025 |
|
| Insight Holdings | 989k | $9.3M | 0% | Dec 2025 |
|
| Woodline Partners | 845k | $7.9M | 235% | Dec 2025 |
|
| Propel Bio Management | 667k | $6.3M | 100% | Dec 2025 |
|
| Mbb Public Markets I | 615k | $5.8M | 0% | Dec 2025 |
|
| Alyeska Investment Group | 600k | $5.6M | 100% | Dec 2025 |
|
| Millennium Management | 552k | $3.3M | 22% | Sep 2025 |
|
| BlackRock | 545k | $5.1M | 13% | Dec 2025 |
|
| RFG Advisory | 445k | $4.2M | 100% | Dec 2025 |
|
| Susquehanna International | 292k | $2.7M | 17% | Dec 2025 |
|
| Heights Capital Management | 272k | $2.6M | 100% | Dec 2025 |
|
| Geode Capital Management | 266k | $2.5M | -4% | Dec 2025 |
|
| Bnp Paribas Arbitrage, Snc | 252k | $2.4M | 641% | Dec 2025 |
|
| Jane Street | 250k | $2.4M | 17% | Dec 2025 |
|
| TD Asset Management | 223k | $2.1M | 35% | Dec 2025 |
|
| UBS Group | 202k | $1.9M | 28% | Dec 2025 |
|
| Burkehill Global Management | 200k | $1.9M | 100% | Dec 2025 |
|
| Monashee Investment Management | 195k | $1.8M | 100% | Dec 2025 |
|
| Simplify Asset Management | 192k | $1.8M | 100% | Dec 2025 |
|
| Peapod Lane Capital | 184k | $1.7M | -42% | Dec 2025 |
|
| Renaissance Technologies | 178k | $1.7M | 8% | Dec 2025 |
|
| Bridgeway Capital Management | 175k | $1.0M | 178% | Sep 2025 |
|
| Barclays | 165k | $1.5M | 116% | Dec 2025 |
|
| Maven Securities | 146k | $1.4M | 100% | Dec 2025 |
|
| Squarepoint Ops | 139k | $1.3M | 100% | Dec 2025 |
|
| Marshall Wace | 136k | $1.3M | 100% | Dec 2025 |
|
| Manufacturers Life Insurance Company | 135k | $1.3M | 30% | Dec 2025 |
|
| Goldman Sachs Group | 134k | $1.3M | 210% | Dec 2025 |
|
| Kera Capital Partners | 133k | $1.1M | -69% | Dec 2025 |
|
| Two Sigma Investments | 133k | $795k | 10% | Sep 2025 |
|
| Stifel Financial | 126k | $1.2M | 224% | Dec 2025 |
|
| Charles Schwab Investment Management | 125k | $1.2M | 0% | Dec 2025 |
|
| 683 Capital Management | 115k | $1.1M | 100% | Dec 2025 |
|
| Jacobs Levy Equity Management | 109k | $1.0M | -27% | Dec 2025 |
|
| State Street Corporation | 91k | $858k | 0% | Dec 2025 |
|
| Hudson Bay Capital Management | 89k | $832k | 100% | Dec 2025 |
|
| Citadel Advisors | 85k | $512k | -77% | Sep 2025 |
|
| Two Sigma Advisers | 81k | $488k | -14% | Sep 2025 |
|
| Jump Financial | 80k | $755k | 100% | Dec 2025 |
|
| Dimensional Fund Advisors | 78k | $737k | 100% | Dec 2025 |
|
| Wells Fargo & Company | 75k | $705k | 310% | Dec 2025 |
|
| Ing Investment Management | 68k | $641k | 100% | Dec 2025 |
|
| Qube Research & Technologies | 64k | $598k | 73% | Dec 2025 |
|
| ADAR1 Capital Management | 57k | $540k | 100% | Dec 2025 |
|
| Quadrature Capital | 57k | $539k | 100% | Dec 2025 |
|
| Nano Cap New Millennium Growth Fund | 54k | $503k | 100% | Dec 2025 |
|
| Northern Trust | 52k | $485k | 0% | Dec 2025 |
|
| American Century Companies | 46k | $436k | 44% | Dec 2025 |
|
| OMERS Administration Corporation | 35k | $327k | 100% | Dec 2025 |
|
| Point72 Asset Management | 32k | $303k | 18% | Dec 2025 |
|
| Leucadia National Corporation | 32k | $301k | 96% | Dec 2025 |
|
| Schonfeld Strategic Advisors | 29k | $271k | 100% | Dec 2025 |
|
| ACT Capital Management | 25k | $236k | 100% | Dec 2025 |
|
| Raymond James Financial | 25k | $236k | 100% | Dec 2025 |
|
| XTX Topco | 23k | $219k | -53% | Dec 2025 |
|
| Federated Investors | 21k | $195k | 37% | Dec 2025 |
|
| Cubist Systematic Strategies | 20k | $123k | -86% | Sep 2025 |
|
| Springbok Capital Management | 19k | $117k | -46% | Sep 2025 |
|
| JustInvest | 19k | $179k | 1% | Dec 2025 |
|
| Caxton | 19k | $177k | -18% | Dec 2025 |
|
| Cambria Investment Management | 18k | $169k | 100% | Dec 2025 |
|
| Quest Partners | 16k | $154k | 100% | Dec 2025 |
|
| AQR Capital Management | 14k | $81k | -86% | Sep 2025 |
|
| Ethic | 13k | $119k | -18% | Dec 2025 |
|
| Phoenix Wealth Advisors | 12k | $116k | 17% | Dec 2025 |
|
| Point72 Asia | 11k | $65k | -10% | Sep 2025 |
|
| EntryPoint Capital | 10k | $95k | 100% | Dec 2025 |
|
| Capital Advisors | 10k | $94k | 0% | Dec 2025 |
|
| FMR | 7.9k | $48k | -3% | Sep 2025 |
|
| DekaBank Deutsche Girozentrale | 7.5k | $197k | 0% | Dec 2025 |
|
| China Universal Asset Management | 7.1k | $67k | -6% | Dec 2025 |
|
| Jpmorgan Chase & Co | 6.7k | $40k | 100% | Sep 2025 |
|
| Tower Research Capital | 5.1k | $48k | -19% | Dec 2025 |
|
| Ohio Pers | 4.6k | $28k | 100% | Sep 2025 |
|
| Deutsche Bank Aktiengesellschaft | 3.9k | $37k | 0% | Dec 2025 |
|
| Advisor Group Holdings | 3.2k | $30k | 29% | Dec 2025 |
|
| Mirae Asset Global Investments | 2.1k | $20k | 27% | Dec 2025 |
|
| Royal Bank of Canada | 2.0k | $0 | 115% | Sep 2025 |
|
| Pnc Financial Services | 1.7k | $16k | 0% | Dec 2025 |
|
| Russell Investments | 1.3k | $12k | 0% | Dec 2025 |
|
| Vermillion & White Wealth Management Group | 1.1k | $10k | 100% | Dec 2025 |
|
| Gf Fund Management | 860.00 | $8.1k | -4% | Dec 2025 |
|
| National Bank Of Canada /fi/ | 400.00 | $3.8k | 100% | Dec 2025 |
|
| NISA Investment Advisors | 301.00 | $2.8k | 0% | Dec 2025 |
|
| TFC Financial Management | 300.00 | $2.8k | 100% | Dec 2025 |
|
| CWM | 263.00 | $2.0k | -47% | Dec 2025 |
|
| Fourth Dimension Wealth | 250.00 | $2.4k | 0% | Dec 2025 |
|
| EverSource Wealth Advisors | 163.00 | $1.5k | -18% | Dec 2025 |
|
| Jones Financial Companies, L.L | 37.00 | $347.999800 | 100% | Dec 2025 |
|
| Parallel Advisors | 26.00 | $243.999600 | 100% | Dec 2025 |
|
| SBI Securities | 22.00 | $207.000200 | -84% | Dec 2025 |
|
| SRS Capital Advisors | 11.00 | $102.999600 | 0% | Dec 2025 |
|
Who sold out of Kyverna Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Franklin Resources | Sep 2025 | 678k | $4.1M |
| Catalio Capital Management | Sep 2025 | 587k | $3.5M |
| Trexquant Investment | Sep 2025 | 15k | $91k |
| Ameriprise Financial | Sep 2025 | 13k | $77k |
| Point72 | Jun 2025 | 1.7k | $5.2k |
| Advisory Services Network | Sep 2025 | 86.00 | $516.000000 |
| IFP Advisors | Sep 2025 | 16.00 | $96.000000 |